Plums, have you tried Renovo for a response.
Like a dog with a bone, I can't let this go.
After Ryans appointment as Senior Vice President, Head of Corporate Strategy and Partnerships & with everything going on in the Renovo camp why did he choose to pick Imugene out in his quote
“RenovoRx is at an important juncture, and I am excited to step into this role on a permanent basis,” said Mr. Witt. “Building off our collaboration with Imugene and clinical data delivering gemcitabine with our drug-delivery platform, there is incredible potential for RenovoRx’s technology.
Ryan Witt
Right or wrong we have a proxy listing on the Nasdaq in RenovoRx, the oncology world will be watching IMU if this eventuates.
RNXT up 6% on the news.
imo dyor
Foil hat off.
Media Thread, page-14589
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.7¢ | 4.5¢ | $906.2K | 19.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9543864 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 1266571 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |